Jennifer L. Taubert - 04 Sep 2025 Form 4 Insider Report for JOHNSON & JOHNSON (JNJ)

Signature
/s/ Laura H. McFalls, as attorney-in-fact for Jennifer Taubert
Issuer symbol
JNJ
Transactions as of
04 Sep 2025
Net transactions value
-$10,040,883
Form type
4
Filing time
05 Sep 2025, 18:00:47 UTC
Previous filing
01 Jul 2025
Next filing
01 Oct 2025

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Taubert Jennifer L EVP, WWC. Innovative Medicine ONE JOHNSON & JOHNSON PLAZA, NEW BRUNSWICK /s/ Laura H. McFalls, as attorney-in-fact for Jennifer Taubert 05 Sep 2025 0001745938

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction JNJ Common Stock Options Exercise $5,752,701 +56,471 +32% $101.87 234,484 04 Sep 2025 Direct
transaction JNJ Common Stock Sale $10,040,883 -56,471 -24% $177.81 178,013 04 Sep 2025 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction JNJ Employee Stock Options (Right to Buy) Options Exercise $5,752,701 -56,471 -100% $101.87 0 04 Sep 2025 Common Stock 56,471 $101.87 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This transaction was executed in multiple trades at prices ranging from $177.715 to $177.89. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide, upon request, to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F2 Vested and exercisable one day after the third anniversary of the date of the grant.